Health of HIV infected people . Volume II, : food, nutrition and lifestyle without antiretroviral drugs / / edited by Ronald Ross Watson |
Pubbl/distr/stampa | Amsterdam, [Netherlands] : , : Academic Press, , 2015 |
Descrizione fisica | 1 online resource (421 p.) |
Disciplina | 616.979206 |
Soggetto topico |
AIDS (Disease) - Alternative treatment
HIV-positive persons - Health and hygiene Antiretroviral agents |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Front Cover; Health of HIV infected People; Copyright Page; Contents; Preface; List of Contributors; Acknowledgement; I. Overview and Food; 1 Dietary Supplements Among People Living with HIV and Vulnerability to Medical Internet Misinformation; 1.1 Section 1: Complementary and Alternative Medicine Use Among People Living with HIV; 1.2 Section 2: Correlates of CAM Use Among People Living with HIV; 1.3 Section 3: Efficacy and Utility of CAM for People Living with HIV; 1.4 Section 4: Disclosure of CAM Use to Standard HIV Care Providers
1.5 Section 5: Seeking Information About Herbal Supplements and Other CAM1.6 Section 6: Recommendations for Patients; 1.7 Section 7: Recommendations for Providers; 1.8 Section 8: Recommendations for Researchers; 1.9 Section 9: Summary; Acknowledgment; References; 2 Eating Coffee Candy: HIV Risk at Huli Funerals; 2.1 Method; 2.2 Results: Eating Coffee and Candy at Huli Funerals; 2.3 Discussion: "Eat and Die"; 2.4 Responses; References; 3 Infant Feeding Policies and HIV; 3.1 Introduction; 3.2 To Breastfeed or Not to Breastfeed? Is That the Right Question? 3.2.1 Quantifying the Magnitude of Breastfeeding-Associated HIV Infection3.2.2 Quantifying the Magnitude of Risks Associated with Not Breastfeeding; 3.2.3 How Do the Numbers Stack Up?; 3.3 Harm Reduction Approaches; 3.3.1 Exclusive Breastfeeding; 3.3.2 Early Weaning; 3.3.3 When Is Avoidance of Breastfeeding AFASS?; 3.4 Antiretroviral Interventions Transform the Policy Arena; 3.5 Key Gaps in Infant Feeding Policies and HIV; References; 4 Alcohol Use and Food Insecurity in HIV Disease Management; 4.1 Food Insecurity and HIV Disease; 4.2 Alcohol Misuse and HIV Disease 4.3 Food and Alcohol as Competing Needs4.4 Food Insecurity, Alcohol Misuse, and HIV Disease; 4.5 HIV Treatment Adherence; 4.6 Implications for Interventions; 4.7 Conclusions; Acknowledgment; References; 5 Carotid Intima-Media Thickness and Plaque in HIV-Infected Patients on the Mediterranean Diet; 5.1 Introduction; 5.2 Ultrasound Measurement of CIMT; 5.3 Characteristics of Mediterranean Diet; 5.4 CIMT in HIV-Infected Patients; 5.5 CIMT in HIV-Infected Patients Adherent to Mediterranean Diet; References; II. Nutrition and Lifestyle 6 Nutritional Treatment Approach for ART-Naïve HIV-Infected Children6.1 Introduction; 6.1.1 Proposals and Investigations About Nutritional Approach for HIV-Infected Children; 6.2 Nutritional Treatment and Ready-to-Use Formulas; 6.2.1 Breastfeeding; 6.2.2 Weaning and Complementary Feeding; 6.3 Vitamins and Minerals; 6.3.1 Iron; 6.3.2 Zinc; 6.3.3 Vitamin A; 6.3.4 Vitamin D and Calcium; 6.3.5 Micronutrients; 6.4 Probiotics; 6.5 Conclusion; References; 7 Nutrition Therapy for HAART-Naïve HIV-Infected Patients; 7.1 Introduction; 7.2 Malnutrition and Diarrhea; 7.3 Minerals; 7.3.1 Iron; 7.3.2 Zinc 7.3.3 Selenium |
Record Nr. | UNINA-9910788287003321 |
Amsterdam, [Netherlands] : , : Academic Press, , 2015 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Health of HIV infected people . Volume I : food, nutrition and lifestyle with antiretroviral drugs / / edited by Ronald Ross Watson |
Pubbl/distr/stampa | Amsterdam, [Netherlands] : , : Academic Press, , 2015 |
Descrizione fisica | 1 online resource (633 p.) |
Disciplina | 616.979206 |
Soggetto topico |
HIV-positive persons - Health and hygiene
AIDS (Disease) - Treatment Antiretroviral agents |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Front Cover; Health of HIV Infected People; Copyright Page; Contents; Preface; List of Contributors; Acknowledgement; I. Food and Overview; 1 Exercise and Rehabilitation; 1.1 Introduction; 1.2 Quality of Life; 1.3 Exercise and HAART; 1.3.1 Exercise Activities; 1.3.2 Rebound Exercise; 1.3.3 Studies with Rebound Exercise; 1.3.4 Precautions During Rebound Exercise; 1.3.5 Physiologic Responses Following Rebound Exercise; 1.3.6 Rebound Exercise and QoL; 1.4 Summary and Clinical Implications; References
2 Metabolic Abnormalities in HIV-Infected Populations without or with Antiretroviral Therapy (ART)2.1 Introduction; 2.1.1 Metabolic Abnormalities; 2.1.2 Grading of Severity in Dyslipidemia and Abnormal Glucose Level; 2.1.3 Anti-HIV Drugs by Class; 2.2 HIV-Associated Metabolic Abnormalities Without ART; 2.2.1 Pathophysiology of Serum Lipid Disorders; 2.2.2 Studies on Serum Lipid Disorders; 2.2.3 Serum Glucose Disorders; 2.2.4 Pathophysiology of Serum Glucose Disorders; 2.3 HIV-Associated Metabolic Abnormalities with ART; 2.3.1 Serum Lipid Disorders; 2.3.1.1 Epidemiology 2.3.2 Protease Inhibitors2.3.2.1 Mechanisms of PIs; 2.3.2.2 Dyslipidemia and PIs; 2.3.3 Nucleoside Reverse-Transcriptase Inhibitors; 2.3.3.1 Mechanism of NRTIs; 2.3.3.2 Dyslipidemia and NRTIs; 2.3.4 Non-nucleoside Reverse-Transcriptase Inhibitors; 2.3.4.1 Mechanism of NNRTIs; 2.3.4.2 Dyslipidemia and NNRTIs; 2.3.5 Dyslipidemia and Integrase Inhibitor and CCR Antagonist; 2.3.6 Glucose Metabolism; 2.3.6.1 Epidemiology; 2.3.6.2 Studies on Glucose Metabolism; 2.3.6.3 Mechanism of Antiretroviral Drugs on Glucose Metabolism; 2.4 Conclusion; References 3 Effects of Dietary Fat Intake on Acquired Immune Deficiency Syndrome During Antiretroviral Therapy3.1 Introduction; 3.1.1 Dietary Fat Intake in Health; 3.1.2 Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome; 3.2 Dietary Fat Intake: A Role in HIV/AIDS; 3.3 Dietary Fat Intake and HIV/AIDS: Clinical Trials; 3.4 Conclusion; References; 4 Human Immunodeficiency Virus Infection-Associated Cancer and Mycotoxins in Food; 4.1 Epidemiology of Human Immunodeficiency Virus Infection; 4.2 Pathophysiology of HIV Infection with Immune Interference 4.3 Development of Cancer in a Patient with HIV4.4 Patients with HIV and ADCs; 4.5 HIV-Infected Patients with NADCs; 4.6 Mycotoxins in Patients with HIV; References; 5 Effects of Omega-3 Fatty Acids on Body Composition and Health in HIV/AIDS During HAART Therapy; 5.1 Introduction; 5.2 Signs and Symptoms; 5.3 Transmission; 5.4 Correlation of Dietary Fats and HIV; 5.5 Diagnosis and Treatment; 5.6 Antiretroviral Therapy; 5.7 Glucose Tolerance Overview; 5.8 Saturated Fatty Acids and HIV/AIDS; 5.9 Unsaturated Fatty Acids and HIV/AIDS; 5.10 Omega-3 Fatty Acids and HIV/AIDS 5.11 HIV/AIDS and Dietary Fat Supplementation |
Record Nr. | UNINA-9910788287103321 |
Amsterdam, [Netherlands] : , : Academic Press, , 2015 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Health of HIV infected people . Volume II, : food, nutrition and lifestyle without antiretroviral drugs / / edited by Ronald Ross Watson |
Pubbl/distr/stampa | Amsterdam, [Netherlands] : , : Academic Press, , 2015 |
Descrizione fisica | 1 online resource (421 p.) |
Disciplina | 616.979206 |
Soggetto topico |
AIDS (Disease) - Alternative treatment
HIV-positive persons - Health and hygiene Antiretroviral agents |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Front Cover; Health of HIV infected People; Copyright Page; Contents; Preface; List of Contributors; Acknowledgement; I. Overview and Food; 1 Dietary Supplements Among People Living with HIV and Vulnerability to Medical Internet Misinformation; 1.1 Section 1: Complementary and Alternative Medicine Use Among People Living with HIV; 1.2 Section 2: Correlates of CAM Use Among People Living with HIV; 1.3 Section 3: Efficacy and Utility of CAM for People Living with HIV; 1.4 Section 4: Disclosure of CAM Use to Standard HIV Care Providers
1.5 Section 5: Seeking Information About Herbal Supplements and Other CAM1.6 Section 6: Recommendations for Patients; 1.7 Section 7: Recommendations for Providers; 1.8 Section 8: Recommendations for Researchers; 1.9 Section 9: Summary; Acknowledgment; References; 2 Eating Coffee Candy: HIV Risk at Huli Funerals; 2.1 Method; 2.2 Results: Eating Coffee and Candy at Huli Funerals; 2.3 Discussion: "Eat and Die"; 2.4 Responses; References; 3 Infant Feeding Policies and HIV; 3.1 Introduction; 3.2 To Breastfeed or Not to Breastfeed? Is That the Right Question? 3.2.1 Quantifying the Magnitude of Breastfeeding-Associated HIV Infection3.2.2 Quantifying the Magnitude of Risks Associated with Not Breastfeeding; 3.2.3 How Do the Numbers Stack Up?; 3.3 Harm Reduction Approaches; 3.3.1 Exclusive Breastfeeding; 3.3.2 Early Weaning; 3.3.3 When Is Avoidance of Breastfeeding AFASS?; 3.4 Antiretroviral Interventions Transform the Policy Arena; 3.5 Key Gaps in Infant Feeding Policies and HIV; References; 4 Alcohol Use and Food Insecurity in HIV Disease Management; 4.1 Food Insecurity and HIV Disease; 4.2 Alcohol Misuse and HIV Disease 4.3 Food and Alcohol as Competing Needs4.4 Food Insecurity, Alcohol Misuse, and HIV Disease; 4.5 HIV Treatment Adherence; 4.6 Implications for Interventions; 4.7 Conclusions; Acknowledgment; References; 5 Carotid Intima-Media Thickness and Plaque in HIV-Infected Patients on the Mediterranean Diet; 5.1 Introduction; 5.2 Ultrasound Measurement of CIMT; 5.3 Characteristics of Mediterranean Diet; 5.4 CIMT in HIV-Infected Patients; 5.5 CIMT in HIV-Infected Patients Adherent to Mediterranean Diet; References; II. Nutrition and Lifestyle 6 Nutritional Treatment Approach for ART-Naïve HIV-Infected Children6.1 Introduction; 6.1.1 Proposals and Investigations About Nutritional Approach for HIV-Infected Children; 6.2 Nutritional Treatment and Ready-to-Use Formulas; 6.2.1 Breastfeeding; 6.2.2 Weaning and Complementary Feeding; 6.3 Vitamins and Minerals; 6.3.1 Iron; 6.3.2 Zinc; 6.3.3 Vitamin A; 6.3.4 Vitamin D and Calcium; 6.3.5 Micronutrients; 6.4 Probiotics; 6.5 Conclusion; References; 7 Nutrition Therapy for HAART-Naïve HIV-Infected Patients; 7.1 Introduction; 7.2 Malnutrition and Diarrhea; 7.3 Minerals; 7.3.1 Iron; 7.3.2 Zinc 7.3.3 Selenium |
Record Nr. | UNINA-9910828099603321 |
Amsterdam, [Netherlands] : , : Academic Press, , 2015 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Health of HIV infected people . Volume I : food, nutrition and lifestyle with antiretroviral drugs / / edited by Ronald Ross Watson |
Pubbl/distr/stampa | Amsterdam, [Netherlands] : , : Academic Press, , 2015 |
Descrizione fisica | 1 online resource (633 p.) |
Disciplina | 616.979206 |
Soggetto topico |
HIV-positive persons - Health and hygiene
AIDS (Disease) - Treatment Antiretroviral agents |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Front Cover; Health of HIV Infected People; Copyright Page; Contents; Preface; List of Contributors; Acknowledgement; I. Food and Overview; 1 Exercise and Rehabilitation; 1.1 Introduction; 1.2 Quality of Life; 1.3 Exercise and HAART; 1.3.1 Exercise Activities; 1.3.2 Rebound Exercise; 1.3.3 Studies with Rebound Exercise; 1.3.4 Precautions During Rebound Exercise; 1.3.5 Physiologic Responses Following Rebound Exercise; 1.3.6 Rebound Exercise and QoL; 1.4 Summary and Clinical Implications; References
2 Metabolic Abnormalities in HIV-Infected Populations without or with Antiretroviral Therapy (ART)2.1 Introduction; 2.1.1 Metabolic Abnormalities; 2.1.2 Grading of Severity in Dyslipidemia and Abnormal Glucose Level; 2.1.3 Anti-HIV Drugs by Class; 2.2 HIV-Associated Metabolic Abnormalities Without ART; 2.2.1 Pathophysiology of Serum Lipid Disorders; 2.2.2 Studies on Serum Lipid Disorders; 2.2.3 Serum Glucose Disorders; 2.2.4 Pathophysiology of Serum Glucose Disorders; 2.3 HIV-Associated Metabolic Abnormalities with ART; 2.3.1 Serum Lipid Disorders; 2.3.1.1 Epidemiology 2.3.2 Protease Inhibitors2.3.2.1 Mechanisms of PIs; 2.3.2.2 Dyslipidemia and PIs; 2.3.3 Nucleoside Reverse-Transcriptase Inhibitors; 2.3.3.1 Mechanism of NRTIs; 2.3.3.2 Dyslipidemia and NRTIs; 2.3.4 Non-nucleoside Reverse-Transcriptase Inhibitors; 2.3.4.1 Mechanism of NNRTIs; 2.3.4.2 Dyslipidemia and NNRTIs; 2.3.5 Dyslipidemia and Integrase Inhibitor and CCR Antagonist; 2.3.6 Glucose Metabolism; 2.3.6.1 Epidemiology; 2.3.6.2 Studies on Glucose Metabolism; 2.3.6.3 Mechanism of Antiretroviral Drugs on Glucose Metabolism; 2.4 Conclusion; References 3 Effects of Dietary Fat Intake on Acquired Immune Deficiency Syndrome During Antiretroviral Therapy3.1 Introduction; 3.1.1 Dietary Fat Intake in Health; 3.1.2 Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome; 3.2 Dietary Fat Intake: A Role in HIV/AIDS; 3.3 Dietary Fat Intake and HIV/AIDS: Clinical Trials; 3.4 Conclusion; References; 4 Human Immunodeficiency Virus Infection-Associated Cancer and Mycotoxins in Food; 4.1 Epidemiology of Human Immunodeficiency Virus Infection; 4.2 Pathophysiology of HIV Infection with Immune Interference 4.3 Development of Cancer in a Patient with HIV4.4 Patients with HIV and ADCs; 4.5 HIV-Infected Patients with NADCs; 4.6 Mycotoxins in Patients with HIV; References; 5 Effects of Omega-3 Fatty Acids on Body Composition and Health in HIV/AIDS During HAART Therapy; 5.1 Introduction; 5.2 Signs and Symptoms; 5.3 Transmission; 5.4 Correlation of Dietary Fats and HIV; 5.5 Diagnosis and Treatment; 5.6 Antiretroviral Therapy; 5.7 Glucose Tolerance Overview; 5.8 Saturated Fatty Acids and HIV/AIDS; 5.9 Unsaturated Fatty Acids and HIV/AIDS; 5.10 Omega-3 Fatty Acids and HIV/AIDS 5.11 HIV/AIDS and Dietary Fat Supplementation |
Record Nr. | UNINA-9910828099703321 |
Amsterdam, [Netherlands] : , : Academic Press, , 2015 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
HIV/AIDS : oxidative stress and dietary antioxidants / / edited by Victor R. Preedy, King's College London, London, United Kingdom, Ronald Ross Watson, University of Arizona, Mel and Enid Zuckerman College of Public Health, and School of Medicine, Arizona Health Sciences Center, Tucson, AZ, USA |
Pubbl/distr/stampa | London : , : Elsevier, , [2018] |
Descrizione fisica | 1 online resource (xiii, 267 pages) : illustrations |
Disciplina | 616.07 |
Collana | Gale eBooks |
Soggetto topico |
HIV infections
AIDS (Disease) Oxidative stress Antioxidants - Therapeutic use |
ISBN |
0-12-809854-6
0-12-809853-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Antioxidant status in human immunodeficiency virus infection in different clinical conditions / Lizette Gil-Del Valle and Rosario Gravier-Hernández -- Oxidative stress and tuberculosis-human immunodeficiency virus coinfection / Rosario Gravier-Hernández and Lizette Gil-Del Valle -- Dysfunctional high-density lipoprotein in relation to oxidative stress and human immunodeficiency virus / Vasiliki D. Papakonstantinou and Theodoros Kelesidis -- Aging with HIV and oxidative stress / Ilaria Motta and Andrea Calcagno -- Antioxidants in breast milk of lactating mothers with HIV / Sheu K. Rahamon, Abdulfatah A. Onifade and Olatunbosun G. Arinola -- Oxidative stress in HIV in relation to metals / Zephy Doddigarla, Lingidi J. Lakshmi, Jamal Ahmad and Muhammad Faisal -- HIV and gender differences in diet / Ajibola I. Abioye and Wafaie W. Fawzi -- Knowledge, attitude, and practices of HIV positive adults in India -- Deepika Anand and Seema Puri -- Antioxidants in HIV in Africa / Germaine S. Nkengfack Nembongwe and Heike Englert -- Gene delivery of antioxidant enzymes in HIV-1-associated neurocognitive disorder / Jean-Pierre Louboutin and David S. Strayer -- Genistein and HIV infection / Jia Guo and Yuntao Wu -- Opportunistic infections in HIV individuals and enhanced immunity by glutathione / Alexis Alejandre, Leslie Gonzalez, Parveen Hussain, Judy Ly, Anand Muthiah, Tommy Saing, Anddre Valdivia and Vishwantha Venketaraman -- Plectranthus barbatus / Petrina Kapewangolo and Debra Meyer -- Methyl Gallate as an antioxidant and anti-HIV agent / Tzi B. Ng, Jack H. Wong, Chit Tam, Fang Liu, Chi F. Cheung Charlene C. W. Ng, Ryan Tse, Tak F. Tse and Helen Chan -- Taurine and oxidative stress in HIV / Roberto C. Burini, Maria D. Borges-Santos, Fernando Moreto and Yong Ming-Yu -- Mg-supplementation protects against oxidative stress and cardiac dysunction in chronic highly active antiretroviral therapy-treated rats / Jay H. Kramer, Chris F. Spurney, Joanna J. Chmielinska, William B. Weglicki and Ivan T. Mak -- Selenium supplementation, antioxidant effects, and immune restorative effects in immunodeficiency virus / Justin Dong, Anand Muthiah, Parveen Hussain, Miya Yoshida, and Vishwanath Venketaraman -- Vitamin D, oxidative stress, and the antiretroviral tenofovir / Antonio C. Seguro, Pedro H. França Gois and Danielle Canale -- Vitamin E and testicular damage protection in highly active antiretroviral therpay / Onyemaechi O. Azu and Edwin C.S. Naidu -- Assessment of antioxidant potential of dietary components / Shashank Kumar, Rapalli Krishna Cahitanya and Victor R. Preedy -- Recommended resources on the role of oxidative stress and dietary antioxidants in HIV infection and AIDS / Rajkumar Rajendram, Vinood B. Patel and Victor R. Preedy. |
Record Nr. | UNINA-9910583397503321 |
London : , : Elsevier, , [2018] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Immune dysfunction and immunotherapy in heart disease [[electronic resource] /] / edited by Ronald Ross Watson & Douglas F. Larson |
Pubbl/distr/stampa | Oxford, : Blackwell, 2007 |
Descrizione fisica | 1 online resource (323 p.) |
Disciplina |
616.1/207
616.1207 |
Altri autori (Persone) |
WatsonRonald R (Ronald Ross)
LarsonDouglas F |
Soggetto topico |
Heart - Diseases - Immunological aspects
Heart - Diseases - Immunotherapy Immunologic diseases - Complications |
Soggetto genere / forma | Electronic books. |
ISBN |
1-281-06941-8
9786611069414 0-470-69232-4 0-470-76651-4 |
Classificazione | YB 9022 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Immune Dysfunction and Immunotherapy in Heart Disease; Contents; Contributors; Preface; About the Editors; Part I Immune dysfunction leading to heart disease: induction by physiological changes; 1 Immunosuppression by ultraviolet light-B radiation: a mediator of cardiac remodeling; 2 Immune mechanisms in pediatric cardiovascular disease; 3 Heart failure-role of autoimmunity; 4 Immune basis of hypertension in humans; 5 Immune dysregulation: potential mediator metabolic syndrome-induced cardiac remodeling; 6 T helper 2 cell cytokines in remodeling of aortic wall
7 Effects of TNF-a on cardiac function8 Immunosuppression in promotion of cardiac allograft vasculopathy; 9 Immunotherapy for left ventricular dysfunction after heart transplantation; Part II Immune dysfunction promoting CVD: induction by transplantation drugs; 10 Immunomodulating therapy in chronic heart failure; 11 Statins in atherosclerosis: role of immune regulation; 12 ACE inhibitors as immunomodulators: treatment of cardiovascular disease; 13 Treatment of heart failure by anticytokine therapies Part III Immune dysfunction leading to heart dysfunction: induction or prevention by cardiotherapeutic drugs14 Pathogenesis of cardiovascular complications in the acquired immunodeficiency syndrome; 15 Cytokines and T cell-mediated responses in autoimmune myocarditis; 16 Drugs of abuse: accentuation of immunomodulation of viral myocarditis; Part IV Immune dysfunction leading to heart disease: induction by pathogens; 17 Osteopontin: the link between the immune system and cardiac remodeling; 18 Inflammatory immune activation in heart failure patients: therapeutic implications 26 Role of oral pathogens in the pathogenesis of coronary heart disease27 Myocardial regenerative potential by stem cell transplant; 28 Bioflavanoids and dietary anti-inflammatory actions: role in cardiovascular diseases; Index |
Record Nr. | UNINA-9910145440203321 |
Oxford, : Blackwell, 2007 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Immune dysfunction and immunotherapy in heart disease [[electronic resource] /] / edited by Ronald Ross Watson & Douglas F. Larson |
Pubbl/distr/stampa | Oxford, : Blackwell, 2007 |
Descrizione fisica | 1 online resource (323 p.) |
Disciplina |
616.1/207
616.1207 |
Altri autori (Persone) |
WatsonRonald R (Ronald Ross)
LarsonDouglas F |
Soggetto topico |
Heart - Diseases - Immunological aspects
Heart - Diseases - Immunotherapy Immunologic diseases - Complications |
ISBN |
1-281-06941-8
9786611069414 0-470-69232-4 0-470-76651-4 |
Classificazione | YB 9022 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Immune Dysfunction and Immunotherapy in Heart Disease; Contents; Contributors; Preface; About the Editors; Part I Immune dysfunction leading to heart disease: induction by physiological changes; 1 Immunosuppression by ultraviolet light-B radiation: a mediator of cardiac remodeling; 2 Immune mechanisms in pediatric cardiovascular disease; 3 Heart failure-role of autoimmunity; 4 Immune basis of hypertension in humans; 5 Immune dysregulation: potential mediator metabolic syndrome-induced cardiac remodeling; 6 T helper 2 cell cytokines in remodeling of aortic wall
7 Effects of TNF-a on cardiac function8 Immunosuppression in promotion of cardiac allograft vasculopathy; 9 Immunotherapy for left ventricular dysfunction after heart transplantation; Part II Immune dysfunction promoting CVD: induction by transplantation drugs; 10 Immunomodulating therapy in chronic heart failure; 11 Statins in atherosclerosis: role of immune regulation; 12 ACE inhibitors as immunomodulators: treatment of cardiovascular disease; 13 Treatment of heart failure by anticytokine therapies Part III Immune dysfunction leading to heart dysfunction: induction or prevention by cardiotherapeutic drugs14 Pathogenesis of cardiovascular complications in the acquired immunodeficiency syndrome; 15 Cytokines and T cell-mediated responses in autoimmune myocarditis; 16 Drugs of abuse: accentuation of immunomodulation of viral myocarditis; Part IV Immune dysfunction leading to heart disease: induction by pathogens; 17 Osteopontin: the link between the immune system and cardiac remodeling; 18 Inflammatory immune activation in heart failure patients: therapeutic implications 26 Role of oral pathogens in the pathogenesis of coronary heart disease27 Myocardial regenerative potential by stem cell transplant; 28 Bioflavanoids and dietary anti-inflammatory actions: role in cardiovascular diseases; Index |
Record Nr. | UNISA-996218596003316 |
Oxford, : Blackwell, 2007 | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
Immune dysfunction and immunotherapy in heart disease [[electronic resource] /] / edited by Ronald Ross Watson & Douglas F. Larson |
Pubbl/distr/stampa | Oxford, : Blackwell, 2007 |
Descrizione fisica | 1 online resource (323 p.) |
Disciplina |
616.1/207
616.1207 |
Altri autori (Persone) |
WatsonRonald R (Ronald Ross)
LarsonDouglas F |
Soggetto topico |
Heart - Diseases - Immunological aspects
Heart - Diseases - Immunotherapy Immunologic diseases - Complications |
ISBN |
1-281-06941-8
9786611069414 0-470-69232-4 0-470-76651-4 |
Classificazione | YB 9022 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Immune Dysfunction and Immunotherapy in Heart Disease; Contents; Contributors; Preface; About the Editors; Part I Immune dysfunction leading to heart disease: induction by physiological changes; 1 Immunosuppression by ultraviolet light-B radiation: a mediator of cardiac remodeling; 2 Immune mechanisms in pediatric cardiovascular disease; 3 Heart failure-role of autoimmunity; 4 Immune basis of hypertension in humans; 5 Immune dysregulation: potential mediator metabolic syndrome-induced cardiac remodeling; 6 T helper 2 cell cytokines in remodeling of aortic wall
7 Effects of TNF-a on cardiac function8 Immunosuppression in promotion of cardiac allograft vasculopathy; 9 Immunotherapy for left ventricular dysfunction after heart transplantation; Part II Immune dysfunction promoting CVD: induction by transplantation drugs; 10 Immunomodulating therapy in chronic heart failure; 11 Statins in atherosclerosis: role of immune regulation; 12 ACE inhibitors as immunomodulators: treatment of cardiovascular disease; 13 Treatment of heart failure by anticytokine therapies Part III Immune dysfunction leading to heart dysfunction: induction or prevention by cardiotherapeutic drugs14 Pathogenesis of cardiovascular complications in the acquired immunodeficiency syndrome; 15 Cytokines and T cell-mediated responses in autoimmune myocarditis; 16 Drugs of abuse: accentuation of immunomodulation of viral myocarditis; Part IV Immune dysfunction leading to heart disease: induction by pathogens; 17 Osteopontin: the link between the immune system and cardiac remodeling; 18 Inflammatory immune activation in heart failure patients: therapeutic implications 26 Role of oral pathogens in the pathogenesis of coronary heart disease27 Myocardial regenerative potential by stem cell transplant; 28 Bioflavanoids and dietary anti-inflammatory actions: role in cardiovascular diseases; Index |
Record Nr. | UNINA-9910830341103321 |
Oxford, : Blackwell, 2007 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Immune dysfunction and immunotherapy in heart disease [[electronic resource] /] / edited by Ronald Ross Watson & Douglas F. Larson |
Pubbl/distr/stampa | Oxford, : Blackwell, 2007 |
Descrizione fisica | 1 online resource (323 p.) |
Disciplina |
616.1/207
616.1207 |
Altri autori (Persone) |
WatsonRonald R (Ronald Ross)
LarsonDouglas F |
Soggetto topico |
Heart - Diseases - Immunological aspects
Heart - Diseases - Immunotherapy Immunologic diseases - Complications |
ISBN |
1-281-06941-8
9786611069414 0-470-69232-4 0-470-76651-4 |
Classificazione | YB 9022 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Immune Dysfunction and Immunotherapy in Heart Disease; Contents; Contributors; Preface; About the Editors; Part I Immune dysfunction leading to heart disease: induction by physiological changes; 1 Immunosuppression by ultraviolet light-B radiation: a mediator of cardiac remodeling; 2 Immune mechanisms in pediatric cardiovascular disease; 3 Heart failure-role of autoimmunity; 4 Immune basis of hypertension in humans; 5 Immune dysregulation: potential mediator metabolic syndrome-induced cardiac remodeling; 6 T helper 2 cell cytokines in remodeling of aortic wall
7 Effects of TNF-a on cardiac function8 Immunosuppression in promotion of cardiac allograft vasculopathy; 9 Immunotherapy for left ventricular dysfunction after heart transplantation; Part II Immune dysfunction promoting CVD: induction by transplantation drugs; 10 Immunomodulating therapy in chronic heart failure; 11 Statins in atherosclerosis: role of immune regulation; 12 ACE inhibitors as immunomodulators: treatment of cardiovascular disease; 13 Treatment of heart failure by anticytokine therapies Part III Immune dysfunction leading to heart dysfunction: induction or prevention by cardiotherapeutic drugs14 Pathogenesis of cardiovascular complications in the acquired immunodeficiency syndrome; 15 Cytokines and T cell-mediated responses in autoimmune myocarditis; 16 Drugs of abuse: accentuation of immunomodulation of viral myocarditis; Part IV Immune dysfunction leading to heart disease: induction by pathogens; 17 Osteopontin: the link between the immune system and cardiac remodeling; 18 Inflammatory immune activation in heart failure patients: therapeutic implications 26 Role of oral pathogens in the pathogenesis of coronary heart disease27 Myocardial regenerative potential by stem cell transplant; 28 Bioflavanoids and dietary anti-inflammatory actions: role in cardiovascular diseases; Index |
Record Nr. | UNINA-9910840878003321 |
Oxford, : Blackwell, 2007 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Lifestyle in heart health and disease / / edited by Ronald Ross Watson, Sherma Zibadi |
Pubbl/distr/stampa | London, England : , : Academic Press, , 2018 |
Descrizione fisica | 1 online resource (319 pages) : illustrations (some color) |
Disciplina | 616.1205 |
Soggetto topico |
Heart - Diseases - Prevention
Lifestyles - Health aspects |
ISBN |
0-12-811280-8
0-12-811279-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910583474103321 |
London, England : , : Academic Press, , 2018 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|